In the present study, the effects of triptolide treatment were determined on multiple breast cancer cell lines, specifically, the highly metastatic MDA-MB-231, human epidermal growth factor receptor (HER2)-positive BT-474 and estrogen receptor (ER)-positive MCF7 cell lines. Here, ESR1 is linked to breast carcinoma.